| 產(chǎn)品名稱 | Lapatinib ditosylate - GW 572016 |
| 產(chǎn)品貨號(hào) | Axon 1395 CAS [388082-77-7] MF C29H26ClFN4O4S.2C7H8O3SMW 925.46 Purity: 99% Soluble in DMSO Description An ATP-competitive epidermal growth factor receptor (EGFR) and HER2/neu (ErbB-2) dual tyrosine kinase inhibitor References Certificates Categories Extra info HA Burris. Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib. Oncologist 2004, 9 Suppl 3: 10–5. ? MH Nelson, CR Dolder. Lapatinib: a novel dual tyrosine kinase inhibitor with activity in solid tumors. Ann Pharmacother 2006, 40(2), 261–9. Certificate of Analysis Material Safety Data Sheet Angiogenesis Cell Signaling & Oncology EGFR ErbB2-HER2 JAK-STAT RTK class I; EC 2.7.10.1 EGFR and ErbB-2/HER2 tyrosine kinase inhibitor Chemical name N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl] quinazolin-4-amine ditosylate Parent CAS No. [231277-92-2] Order Size Unit Price Stock 10 mg €95.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
Lapatinib ditosylate - GW 572016Axon 1395 CAS [388082-77-7] MF C29H26ClFN4O4S.2C7H8O3S
Description
An ATP-competitive epidermal growth factor receptor (EGFR) and HER2/neu (ErbB-2) dual tyrosine kinase inhibitor
EGFR and ErbB-2/HER2 tyrosine kinase inhibitor
Chemical nameN-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl] quinazolin-4-amine ditosylate Parent CAS No.[231277-92-2] |
| 產(chǎn)品資料 |
